S. G. Deeks, S. R. Lewin, and D. V. Havlir, The end of AIDS: HIV infection as a chronic disease, Lancet, vol.382, issue.9903, pp.1525-1558, 2013.

M. Chang, C. Vitek, J. Esparza, and . Who-unaids-cdc, Public health considerations for the use of a first-generation HIV vaccine, AIDS, vol.17, issue.15, pp.1-10, 2002.

O. Launay, D. Hoch, C. Saint-sardos, and D. Guillemot, Participants of round table n°6 of Giens XXV. Vaccines: specific features, simulation of impact and medico-economic modelling, Thérapie, 2010.

G. Carcelain and B. Autran, Immune interventions in HIV infection, Immunol Rev, vol.254, issue.1, pp.355-71, 2013.

R. L. Puls and S. Emery, Therapeutic vaccination against HIV: current progress and future possibilities, Clin Sci, vol.110, issue.1, pp.59-71, 2006.

F. García, A. León, J. M. Gatell, M. Plana, and T. Gallart, Therapeutic vaccines against HIV infection, Hum Vaccin Immunother, vol.8, issue.5, pp.569-81, 2012.

A. P. West, L. Scharf, J. F. Scheid, F. Klein, P. J. Bjorkman et al., Structural insights on the role of antibodies in HIV-1 vaccine and therapy, Cell, vol.156, issue.4, pp.633-681, 2014.

T. A. Day and J. G. Kublin, Lessons learned from HIV Vaccine clinical efficacy trials, Curr HIV Res, vol.11, issue.6, pp.441-450, 2013.

S. Rerks-ngarm, P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu et al., Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand, N Engl J Med, vol.361, issue.23, pp.2209-2229, 2009.

, The SAGE Vaccine Hesitancy Working Group. SAGE working group dealing with vaccine hesitancy, 2012.

P. Peretti-watel, H. J. Larson, J. K. Ward, W. S. Schulz, and P. Verger, Vaccine Hesitancy: Clarifying a Theoretical Framework for an Ambiguous Notion, PLOS Curr Outbreaks, vol.1, 2015.

H. Larson, Negotiating vaccine acceptance in an era of reluctance, Hum Vaccin Immunother, vol.9, issue.8, pp.1779-81, 2013.

J. K. Ward, Rethinking the antivaccine movement concept : a case study of public criticism pf the swine flu vaccine's safety in France, Soc Sci Med, vol.159, pp.48-57, 2016.

J. K. Ward, P. Peretti-watel, H. J. Larson, J. Raude, and P. Verger, Vaccine-criticism on the internet : new insights based on French speaking websites, Vaccine, vol.33, pp.1063-70, 2015.

P. Verger, L. Fressard, and F. Collange, Vaccine hesitancy among general Practitionners and its determinants during controversies : a national crosssectional survey in France, Ebiomedecine, vol.2, issue.8, pp.891-898, 2015.

J. Raude, L. Fressard, A. Gautier, and C. Pulcini, Opening the "Vaccine Hesitancy" black box : how trust in institutions affects French GP's vaccination practices, Expert Rev Vaccines, vol.15, issue.7, pp.937-985, 2016.

P. Peretti-watel, P. Verger, J. Raude, A. Constant, A. Gautier et al., Dramatic change in public attitudes towards vaccination during the 2009 influenza a(H1N1) pandemic in France, Euro Surveill, vol.18, issue.44, 2013.

H. J. Larson, D. Smith, P. Paterson, M. Cumming, E. Eckersberger et al., Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines, Lancet Infect Dis, vol.13, pp.606-619, 2013.

H. J. Larson, A. De-figueiredo, Z. Xiahong, W. S. Schulz, and P. Verger, The state of Vaccine confidence 2016: global insights through a 67-country survey, EBioMedicine, vol.12, pp.295-301, 2016.

M. Schwarzinger, P. Verger, M. Guerville, A. C. Rolland, S. Obadia et al., Positive attitudes of French general practitioners towards a/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?, Vaccine, vol.28, issue.15, pp.2743-2751
URL : https://hal.archives-ouvertes.fr/inserm-00636175

R. Flicoteaux, C. Pulcini, P. Carrieri, M. Schwarzinger, C. Leport et al., Correlates of general practitioner recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (a/H1N1) in France: implications for future vaccination campaigns, Vaccine, vol.32, pp.2281-2288, 2014.

R. Sardy, R. Ecochard, E. Lasserre, J. Dubois, D. Floret et al., Social representations of vaccination among patients and general practitioners: a study based on hierarchized evocation, Sante Publique, vol.24, issue.6, pp.547-60, 2012.

E. Dubé, D. Gagnon, M. Ouakki, and J. A. Bettinger, Understanding Vaccine Hesitancy in Canada: results of a consultation study by the Canadian immunization research network, PLoS One, vol.11, issue.6, p.156118, 2016.

P. Verger, Vaccine Hesitancy among general practitioners and its determinants during controversies: a National Cross-sectional Survey in France, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01816807

P. A. Newman and C. Logie, HIV vaccine acceptability: a systematic review and meta-analysis, AIDS, vol.24, issue.11, pp.1749-56, 2010.

C. Lau, J. P. Stansbury, D. A. Gust, and Z. Kafaar, Social and behavioral science in HIV vaccine trials: a gap assessment of the literature, Expert Rev Vaccines, vol.8, issue.2, pp.179-90, 2009.

Y. Dong, X. Shen, R. Guo, B. Liu, L. Zhu et al., Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China, PLoS One, vol.9, issue.11, p.111321, 2014.

E. Broadbent, K. J. Petrie, J. Main, and J. Weinman, The brief illness perception questionnaire, J Psychosom Res, vol.60, pp.631-638, 2006.

M. Duracinsky, C. Lalanne, L. Coeur, S. Herrmann, S. Berzins et al., Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease, J Acquir Immune Defic Syndr, vol.59, issue.5, pp.506-521, 2012.

K. J. Petrie, E. Broadbent, and G. Meechan, Self-regulatory interventions for improving the management of chronic illness, pp.257-77, 2003.

M. Duracinsky, S. Herrmann, B. Berzins, A. R. Armstrong, R. Kohli et al., The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS, J Acquir Immune Defic Syndr, vol.59, issue.5, pp.498-505, 2012.

C. Lalanne, O. Chassany, P. Carrieri, F. Marcellin, A. R. Armstrong et al., A reduced factor structure for the PROQOL-HIV questionnaire provided reliable indicators of health-related quality of life, J Clin Epidemiol, vol.72, pp.116-141, 2016.

A. Nixon and D. Wild, Methologies for assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Athens: ISPOR 11th annual European congress, 2008.

A. D. Kosinska, T. Bauer, and U. Protzer, Therapeutic vaccination for chronic hepatitis B, Curr Opin Virol, vol.23, pp.75-81, 2017.

A. Yang, J. Jeang, and K. Cheng, Current state in the development of candidate therapeutic HPV vaccines, Expert Rev Vaccines, vol.15, issue.8, pp.989-1007, 2016.

Y. Lobaina, S. Hardtke, H. Wedemeyer, J. C. Aguilar, and V. Schlaphoff, In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors, Mol Immunol, vol.63, issue.2, pp.320-327, 2015.

M. S. Litwin and H. J. Tan, The diagnosis and treatment of prostate Cancer: a review, JAMA, vol.317, issue.24, pp.2532-2574, 2017.

M. Mohseni-zadeh, D. Rey, M. L. Batard, B. Wirth, G. Partisani et al., Inadequate vaccination coverage in a French cohort of HIV positive patients, Med Mal Infect, vol.40, issue.12, pp.683-90, 2010.

T. Douab, F. Marcellin, A. Vilotitch, C. Protopopescu, M. Préau et al., ANRS-VESPA2 study group -health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys), AIDS Care, vol.26, issue.1, pp.29-40, 2014.